Stock Update: Eli Lilly & Company (NYSE:LLY) – EU agency backs new drugs from J&J, Lilly, Takeda

[Reuters] – European regulators said on Friday they had recommended approval of new pills for hepatitis C and diabetes from Johnson & Johnson and Eli Lilly , respectively, and an injectable drug for . . . → Read More: Stock Update: Eli Lilly & Company (NYSE:LLY) – EU agency backs new drugs from J&J, Lilly, Takeda Similar Articles: Company Update – Eli Lilly and Company (NYSE:LLY) – Novartis Veterinary Unit Said to Draw Interest From Merck, Lilly Eli Lilly and Company (NYSE:LLY) – Eli Lilly Bulls: How Will 2014 Treat You? Pfizer 3rd-qtr profit beats estimates; oncology drugs shine – Pfizer Inc. (NYSE:PFE)